Customizing Myopia Control With Multifocal Toric Contact Lens

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04352868
Collaborator
(none)
0
2
24

Study Details

Study Description

Brief Summary

This study will evaluate the ability of toric multifocal contact lens to reduce the change of myopia progression in children (aged 8-12) with myopic astigmatism.

Condition or Disease Intervention/Treatment Phase
  • Device: Intelliwave multifocal, toric, soft contact lens
  • Device: Intelliwave toric, soft contact lens
N/A

Detailed Description

The purpose of this study is to assess if a center distance toric multifocal contact lenses can slow the amount of change of myopia progression in children with myopia plus astigmatism. Multifocal contact lenses have been theorized to influence the peripheral optics of the eye such that they slow the rate of myopia progression in nearsighted children. This outcome is yet to be evaluated in children with myopia plus astigmatism.The secondary outcome is to measure the change in peripheral optics caused by the contact lens. This information is key to understanding the mechanism of multifocal contact lens optics on the eye. Ultimately this information would be used to create a software that can estimate the effect of multifocal contact lenses on the peripheral optics of the child's eye. This software can potentially be used by practitioners worldwide to better customize multifocal contact lenses to slow myopia progression.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Customizing Myopia Control With Multifocal Toric Contact Lens
Anticipated Study Start Date :
Sep 1, 2020
Anticipated Primary Completion Date :
Sep 1, 2021
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Toric soft contact lens

Toric soft contact lens

Device: Intelliwave toric, soft contact lens
This is a quarterly disposable toric soft contact lens commercially available from Art Optical Contact Lens, Inc.

Experimental: Multifocal toric soft contact lens

A multifocal toric soft contact lens with a +2.00 D add.

Device: Intelliwave multifocal, toric, soft contact lens
This is a quarterly disposable, multifocal, toric soft contact lens commercially available from Art Optical Contact Lens, Inc.

Outcome Measures

Primary Outcome Measures

  1. Refractive error progression [1 years]

    Refractive error measured by cycloplegic autorefraction in both eyes, will be measured at baseline and at one year to assess the difference in spherical component of the refractive error between the treatment group (multifocal toric soft contact lens) and the control group (toric soft contact lens)

  2. Axial length [1 years]

    Change in axial length as measured by non-contact axial length both eyes, will be measured at baseline and at one year to assess the difference in change in axial length between the treatment group (multifocal toric soft contact lens) and the control group (toric soft contact lens)

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 8 to 12 years, inclusive, at baseline examination

  • -0.50 to -6.00 D, inclusive, spherical component, cycloplegic autorefraction

  • ≥0.75 DC, cycloplegic autorefraction

  • 0.1 logMAR or better best-corrected visual acuity in each eye

Exclusion Criteria:
  • Eye disease or refractive error conditions (e.g., keratoconus, retinal abnormalities, retinopathy of prematurity, etc.)

  • Ocular surgery, severe ocular trauma, active ocular infection or inflammation

  • Subjects with a condition or in a situation, which in the examiner's opinion, may put the subject at significant risk, may confound the study results, or may significantly interfere with their participation in the study.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Alabama at Birmingham

Investigators

  • Principal Investigator: Andrew D Pucker, OD, PhD, University of Alabama at Birmingham

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andrew Pucker, Assistant Professor, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT04352868
Other Study ID Numbers:
  • IRB-300004596
First Posted:
Apr 20, 2020
Last Update Posted:
Nov 9, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Andrew Pucker, Assistant Professor, University of Alabama at Birmingham
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 9, 2020